News

Events

Chronolife will be at Dublin Tech Summit !
from Apr 10 - 11

Come meet us at booth SU 36
Dublin Tech Summit
CES2019

Chronolife will be at CES – Las Vegas !
from Jan 08 - 11

Meet us in Eureka Park at Business France Pavilion
CES Las Vegas informations
DDI2019
Chronolife est partenaire de l’événement DDI - Assurance Santé Préventive et Prédictive qui aura lieu à Paris le 29 Janvier 2019. Laurent VANDEBROUCK, CEO de CHRONOLIFE interviendra lors de cette conférence concernant la révolution de la Santé préventive et prédictive :

[DE L’IA A l’ANALYSE PREDICTIVE]

Comment améliorer l’observance dans la prévention, les programmes d’efficacité thérapeutique et la télésurveillance de patients atteints de maladies chroniques
  • Atouts et limites de la télésurveillance dans le cas des pathologies complexes
  • Zoom sur les innovations permettant d’améliorer le suivi des patients, y compris en mobilité.
DDI Informations

News

Chronolife launches its connected T-Shirt manufacturing as well as key clinical trial across Europe

Paris (France), January 6th, 2019 - Chronolife, an artificial intelligence company specialized in digital health, announces the launch of the industrialization and production of its connected and washable T-shirt targeting pharma companies, insurance companies and preventive care service providers.

The company recently finalized the development of a washable T-shirt that continuously monitors and collects data on six physiological parameters (electrocardiogram, abdominal breathing, thoracic breathing, pulmonary impedance, physical activity and body temperature). All sensors and electronic components are fully integrated in the fabric of the T-shirt. It is comfortable and washable without the need to extract any electronic component before washing it. The biometrics data collected is transmitted through BlueTooth Low Energy (BTLE) to the user’s smartphone application for continuous data fusion and analysis. Events can be generated by comparing the measurements to an agreed profile, pattern and protocol.

The manufacturing of the Chronolife T-shirt has started so that the clinical trial of the entire end-to-end solution can be launched in the second half of 2019. The solution comprises of the T-Shirt, a smartphone application with HOTS algorithm, an accredited server and a Web interface. The CE marking and commercial release of the solution for remote monitoring and prevention is planned for April 2019. The T-Shirt and associated smartphone application is planned to be a healthcare-graded Class II CE-marking and FDA approved solution for RPM (Remote Patient Monitoring) as from summer 2019. It is planned to be a predictive solution for CHF (Chronic Heart Failure) by summer 2020 following the clinical trial currently launched in Europe.

The clinical trial in Europe will consist in approximately 500 plus heart failure patients from around 20 large hospitals based across France, Denmark and Germany. Patients will be equipped during hospital discharge following a cardiac decompensation. This clinical survey should last a year in Europe. The collected data would allow Chronolife to train and validate its patented algorithm HOTS for detection and prediction of chronic heart failure.

About Chronolife

Chronolife is an artificial intelligence company specialized in digital health. Its patented technology is a unique neuromorphic algorithm called HOTS (Hierarchy Of even-based Time Surfaces), which analyses several data flows continuously, to characterize clinical events. Chronolife has developed a smart wearable that integrates various sensors to monitor physiological data continuously. This data is analyzed by the smartphone application on patient’s phone that uses HOTS technology to conduct data fusion. Chronolife is at the CES (Consumer Electronic Show) this week. Booth 50415 Business France Pavilion , Eureka Park, Sands Expo Convention Center, Venetian Hotel 3355 S Las Vegas Blvd, Las Vegas, NV 89109

To learn more : Chronolife.net or ibionext.com

Press Contact
Agence Weber Shandwick
Natacha Kalasa
chronolife(@)webershandwick.com – 01 47 59 56 33


Laurent Vandebrouck appointed Chief Executive Officer of Chronolife

Paris (France), November 21, 2018 – Chronolife is pleased to announce the appointment of Laurent Vandebrouck to the role of Chief Executive Officer. This start-up co-founded in November 2015 and funded by iBionext is an artificial intelligence company specialized in digital health. Chronolife is currently developing a unique solution which continuously monitors multiple parameters and capable of detecting specific changes in patient’s health.

Before joining Chronolife, Laurent was Managing Director of Qualcomm Life Europe, a company specialized in the development of wireless technologies and the operation of managed services for the connected health market, a company that he joined in 2003. He therefore has a strong experience in connected and digital health including in remote patient monitoring services. He brings his expertise to Chronolife at a time when the company is about to launch a unique range of medical services and devices, starting with a comfortable and washable connected t-shirt that continuously monitors and collects data on 6 physiological parameters (electrocardiogram, abdominal breathing, pulmonary breathing, pulmonary impedance, physical activity and body temperature)

“I am very proud to be joining Chronolife and very enthusiastic at the idea of taking up the firm’s challenges. The technology offered by Chronolife with its connected clothing definitely offers strong competitive advantages. The team has worked brilliantly during the research and development phase by designing a highly innovative and performing t-shirt, which also remains comfortable and discreet”, states Laurent Vandebrouck.

The arrival of Laurent occurs at a strategic moment of the firm’s life, which will now go from its research & development phase, to its manufacturing and commercial phase, requiring the certification of its first medical services and devices.

“We are very pleased to welcome a profile like Laurent to achieve this new step of Chronolife. He is a genuine expert in digital healthcare services, as well as remote patient monitoring services. He also brings a technological perspective, as well as a leadership that will carry us through the next years”, explains Alexia Perouse of iBionext, majority shareholder of Chronolife.

Laurent benefits from more than 25 years of working experience in industry and services, mobile communication technologies, and more recently Cloud and IoT, applied to connected health among other things.

About Chronolife

Chronolife is an artificial intelligence company specialized in digital health. Its patented technology is a unique neuromorphic algorithm called HOTS (Hierarchy Of even-based Time Surfaces), which analyses several data flows continuously, to characterize clinical events. Chronolife has developed a smart wearable that integrates various sensors to continuously monitor physiological data. This data is analyzed by the smartphone application on patient’s phone that uses HOTS technology to conduct data fusion. It is capable of detecting changes in a patient’s health and triggering alerts to healthcare professionals to predict acute pathological episodes.

To learn more: www.chronolife.net or twitter.com/ChronolifeAI

About iBionext

IBionext is a management company that supports and funds the growth of innovative firms in the biotech, medtech and connected medical devices. Initiated as a start-up network since 2012, iBionext helps turning disruptive technologies into innovative firms and worldwide leaders. All of the firms social head offices are gathered within the “Passage de l’Innovation”, Paris. The iBionext network took part in the creation and growth of 9 firms - Pixium Vision (Euronext : PIX), GenSight Biologics (Euronext : SIGHT), Gecko Biomedical, Prophesee, Chronolife, BrainEver, Tilak Healthcare, Gray Matter Labs, Tricper.

To learn more : ibionext.com

¹ IBionext is a management company and studio start-up, specialized in the creation and development of disruptive healthcare companies

Press Contact
Agence Weber Shandwick
Natacha Kalasa
nkalasa(@)webershandwick.com – 01 47 59 56 33

French Version

Chronolife nomme Laurent Vandebrouck en qualité de Directeur Général

Paris (France), le 21 novembre 2018 – Chronolife annonce la nomination de Laurent Vandebrouck au poste de Directeur Général. Cette start-up, co-créée en novembre 2015 et financée par iBionext , est une entreprise d’intelligence artificielle spécialisée dans la santé digitale. Chronolife développe une solution unique de surveillance multiparamétrique, capable de détecter en continu, des changements dans l’état de santé des patients.

Avant de rejoindre Chronolife, Laurent a été Directeur Général Europe de Qualcomm Life, entreprise spécialisée dans le développement de technologies sans fil et l’opération de services de santé connectée, société qu’il a rejoint en 2003. Il dispose donc d’une solide expertise en santé connectée et dans les services de télésurveillance. Il apportera ainsi ses connaissances à Chronolife alors que l’entreprise s’apprête à lancer sa gamme de services et de dispositifs médicaux, à commencer par un T-Shirt connecté, confortable et lavable pour la surveillance et la collecte en continu de 6 données physiologiques (ECG, respiration abdominale, respiration pulmonaire, impédance pulmonaire, activité physique et température du corps).

« Je suis très fier de rejoindre Chronolife et très enthousiaste à l’idée de relever les défis de l’entreprise. La technologie proposée par Chronolife dans son vêtement connecté présente un avantage compétitif certain. L’équipe a accompli un travail formidable durant la phase de recherche & développement en mettant au point un T-shirt hautement innovant et performant tout en étant confortable et discret », déclare Laurent Vandebrouck.

L’arrivée de Laurent intervient à un moment stratégique de la vie de l’entreprise qui va maintenant passer de la phase d’amorçage et de R&D à la phase commerciale et industrielle nécessitant la certification de ses premiers dispositifs et services médicaux.

« Nous sommes ravis d’avoir attiré un profil comme Laurent pour mener à bien cette nouvelle étape de Chronolife. Il est un véritable expert des services de santé connectée et digitale et des services de télésurveillance. Il apporte également une vision technologique ainsi qu’un leadership qui nous guideront au cours des années à venir », explique Alexia Perouse, directrice générale d’iBionext, actionnaire majoritaire de Chronolife.

Laurent profite d’une expérience de plus de 25 ans dans l’industrie et dans les services aux entreprises, dans les technologies de communication mobiles, cellulaires, et plus récemment IoT et Cloud, appliquées, entre autres, à la santé connectée.

A propos de Chronolife

Chronolife est une entreprise d’intelligence artificielle spécialisée dans la santé digitale. Sa technologie brevetée HOTS (Hierarchy Of event-based Time Surfaces) est un algorithme neuromorphique unique qui analyse en continu plusieurs flux de données pour caractériser des événements cliniques. Chronolife a développé un vêtement intelligent intégrant différents capteurs qui mesurent continuellement plusieurs données physiologiques. Ces données sont analysées via l’application Chronolife installée sur le smartphone du patient et qui, par la fusion de ces données et mesures, est capable de détecter des changements dans l’état de santé du patient, d’émettre des événements cliniques et des alertes aux professionnels de santé et enfin de prédire des épisodes pathologiques aigus.

Pour en savoir plus : www.chronolife.net ou twitter.com/ChronolifeAI

À propos d’iBionext

iBionext est une société de gestion qui accompagne et finance la croissance d’entreprises innovantes dans le domaine dans le domaine des biotechs, medtechs et dispositifs médicaux connectés. Initiée sous la forme d’un réseau de start-ups dès 2012, iBionext contribue à transformer de fortes ruptures technologiques en entreprises innovantes et leaders mondiaux. Toutes les entreprises ont leurs sièges sociaux regroupés au sein du « Passage de l’Innovation », Paris. Le réseau iBionext a participé à la création et croissance de 9 entreprises - Pixium Vision (Euronext : PIX), GenSight Biologics (Euronext : SIGHT), Gecko Biomedical, Prophesee, Chronolife, BrainEver, Tilak Healthcare, Gray Matter Labs, Tricper.

Pour en savoir plus : ibionext.com

¹ iBionext est une société de gestion et start-up studio spécialisée dans la construction et le développement d’entreprises disruptives en santé.

Contact presse
Agence Weber Shandwick
Natacha Kalasa
nkalasa(@)webershandwick.com – 01 47 59 56 33

Chronolife Tweets